Insider buying last 90 days
No open-market insider purchases were filed for USPH in the last 90 days.
From Form 4 filings, dated to when each was filed.
Every USPH insider filing, plotted on the chart in Gekko.Open USPH in Gekko
NYSE: USPH
U.S. Physical Therapy (USPH) Stock Analysis & Forecast
Oct 12 close
$85.93+1.26 (+1.5%)
Gekko Brief
AI summaryOct 12 closeU.S. Physical Therapy added Myra Davis to its board effective 1 October, bringing technology and governance experience, alongside continued coverage of second-quarter results showing revenue up 8.5% to $214.1 million on higher clinic visits, even as net income declined to $9.9 million from $12.4 million a year earlier. Analysts have set a consensus target of $98.25 for USPH, implying 17.30% upside from a recent quote, with one commentary citing a fair value estimate near $97.00 tied to record clinic volumes and hospital affiliations.
USPH closed at $85.93, up 1.5%, sitting above both its 50-day average of $80.84 and 200-day average of $76.43, consistent with a supportive longer-term trend. The GekkoIndex reads 50.1, placing the stock in the Neutral zone. Against this, Gekko Fair Value stands at $71.9, putting the current price 19.5% above that level.
Over the next 20 trading days, USPH is scheduled to report earnings on 4 November, 23 days away, which falls within that window. In the past 90 days, Congress members recorded 2 buys and 0 sells. Seasonally, the next 20 trading days from this point in the calendar have averaged a 2.7% gain across 5 years, with gains occurring in 3 of those years. The proximity of earnings alongside the current stretch above Gekko Fair Value are both worth noting.
Written by AI from the Oct 12, 2026 close and checked automatically against the figures on this page.
U.S. Physical Therapy price vs fair value
Close $85.93200-day averageGekko Fair Value $71.90
U.S. Physical Therapy quick facts
- Market cap
- $1.31B
- P/E ratio
- 464
- Forward P/E
- 27.3
- EPS, TTM
- $0.18
- Revenue, TTM
- $804.3M
- Profit margin
- 4%
- Dividend yield
- 2.19%
- Beta
- 1.11
- Volume
- 104,105 avg 187,881
- 1-year return
- −3.3%
- Typical daily move
- ±2.5%
- Typical 20-day move
- ±6.5%
- 50-day average
- $80.84
- 200-day average
- $76.43
- Next earnings
- Nov 4
- Shares outstanding
- 14.92M
U.S. Physical Therapy swing-trade checklist
U.S. Physical Therapy scores 3 supportive, 1 mixed and 2 headwinds across the 6 checklist items with data.
Six things swing traders check before a 20-day hold, read from the latest data.
3 supportive1 mixed2 headwinds
- Trendsupportive
Above 50 and 200-day
Close $85.93 is above the 50-day ($80.84) and 200-day ($76.43) averages, and the 50-day is above the 200-day.
See the chart - GekkoIndexmixed
50.1, Neutral
Reading 50.1 is in the Neutral zone.
See the GekkoIndex - Fair valueheadwind
19.5% above
Price is 19.5% above Gekko Fair Value (more than 5% above).
See fair value - Smart moneysupportive
Leans bullish
Last 90 days: Congress 2 buys / 0 sales.
See smart money - Earnings riskheadwind
Reports in 23 days
Reports on Nov 4, 2026, 23 days away — inside a typical 20-trading-day hold.
See earnings - Seasonalitysupportive
+2.7% on average
From this point in the calendar, the next 20 trading days averaged +2.7% over 5 years, rising in 3 of them.
See seasonality
A description of current data, not a recommendation. How this page works
U.S. Physical Therapy stock chart and price history
U.S. Physical Therapy closed at $85.93 on Oct 12, 2026, −3.3% over the past year, inside a 52-week range of $58.19 to $93.50.
Close50-day average200-day averageVolume
Use the left and right arrow keys to read daily values.
Performance Breakdown
- 1 month
- +9.2%
- 3 months
- +22.8%
- 6 months
- +9.7%
- 1 year
- −3.3%
The full USPH chart adds GekkoIndex, insider, options, Congress and hedge fund markers, plus TrendCandles™.Open USPH in Gekko
Follow U.S. Physical Therapy through every session
Put USPH on a Gekko watchlist and see its GekkoIndex, Gekko Fair Value and smart money signals update on the chart as they change.
Track USPH in GekkoFree for 7 days. No credit card required.
About U.S. Physical Therapy
U.S. Physical Therapy operates a network of outpatient clinics offering care such as pre- and post-surgical rehabilitation, treatment of musculoskeletal problems, recovery support for sports injuries, general preventive health services, injured-worker care, and neurological rehabilitation. The company is best known for running this clinic network through a group of subsidiaries rather than as a single branded operation.
The business is split into two divisions. One covers physical therapy operations delivered through the clinics, while the other, Industrial Injury Prevention Services, focuses on workplace-related care such as on-site injury prevention and recovery programs, performance improvement work, pre-employment screening, functional capacity evaluations, and ergonomic assessments of job sites. These industrial services are carried out by licensed physical therapists and certified athletic trainers, and are used by large corporate clients, including Fortune 500 companies, as well as insurers and their contractors.
The company was founded in 1990 and is headquartered in Houston, Texas. Its shares are listed on the NYSE under the ticker USPH.
- Listed
- NYSE
- Sector
- Health services
- Industry
- Medical/Nursing services
- Website
- usph.com
U.S. Physical Therapy GekkoIndex: the smart money zone
U.S. Physical Therapy’s GekkoIndex — Gekko’s 0 to 100 smart money score — reads 50.1, in the Neutral zone, down 0.6 points over five sessions.
50.1Neutral
Down 0.6 points over five sessions.
Reading for Oct 12, 2026
What followed past readings in each zone
| Zone | Readings | 5 days | 20 days | ||
|---|---|---|---|---|---|
| Buying | 54 | +0.7% | +3.6% | ||
| Accumulation | 255 | −0.2% | +1.3% | ||
| Neutral (current zone) | 344 | +0.3% | −1.5% | ||
| Distribution | 28 | −2.1% | +0.6% | ||
| Selling | 1 | Too few readings yet | |||
Average USPH share-price change over the trading days after each daily reading in its GekkoIndex history. Across every stock Gekko tracks, Neutral readings averaged +1.1% over 20 days. Past behaviour doesn’t guarantee future results.
Neutral zone: No clear directional signal. About the five zones →
See every daily GekkoIndex reading plotted over the USPH price, zone by zone.Track USPH in Gekko
Is U.S. Physical Therapy stock overvalued? Gekko Fair Value
U.S. Physical Therapy trades 19.5% above Gekko Fair Value of $71.90, so the shares are overvalued on Gekko’s estimate.
Gekko’s own estimate of what U.S. Physical Therapy shares are worth, recalculated every trading day.
$71.90
Gekko Fair Value, Oct 10, 2026
19.5% Overvalued
At the end of Aug 2026 the price was 11.4% above the estimate.
Gekko Fair ValueShare price, month end
Gekko Fair Value on every chart, with the gap to price updating daily.Open USPH in Gekko
U.S. Physical Therapy insider and Congress trading
No open-market insider purchases were filed for U.S. Physical Therapy, and members of Congress disclosed 2 purchases and 0 sales, in the last 90 days.
Plus buybacks, unusual options and fund positions, each dated to when it became public.
Congress trades last 90 days
2trades disclosed: 2 purchases and 0 sales.
| Member | Amount | Disclosed |
|---|---|---|
| Gilbert Ray Cisneros House, CA, purchase | $1,001 - $15,000 | Sep 7 traded Jul 16 |
| Gilbert Ray Cisneros House, CA, purchase | $1,001 - $15,000 | Sep 7 traded Jul 15 |
From congressional disclosures, which report amounts as ranges.
Buybacks
U.S. Physical Therapy has been buying back its own shares.
- Bought back, quarter ended Jun 30, 2026
- $19.23M
- As a share of market cap
- 1.47%
From company filings.
U.S. Physical Therapy earnings: next date and track record
U.S. Physical Therapy reports on Nov 4, 2026 (23 days away), and beat the EPS estimate in 3 of its last 8 reports.
Next earnings report
Nov 4, 2026
23 days away
- EPS estimate
- $0.76
- Revenue estimate
- $214.5M
3 of 8reports beat the EPS estimate
±6.6%average move across the report
3 of 8reports followed by a gain
Share-price move across each report
Last earnings call, Feb 26, 2026 AI summary
- What they said
- USPH reported record second quarter results with visits per clinic per day rising to 32.7 from 30.6 prior year. Physical therapy revenues increased 17.3% with over 50 net clinic additions and exceeding 3 million visits year-to-date. Industrial injury prevention revenue grew 22.6% with gross profit up 25.8%. Despite Medicare headwinds impacting earnings by $25 million cumulative, the company achieved strong growth with excellent patient satisfaction scores.
- Guidance
- Management expressed optimism about large industrial contracts coming later in the year, including major opportunities in the auto industry. The company continues to be bullish about the industrial injury prevention business segment.
| Reported | EPS | Revenue | Move |
|---|---|---|---|
| Feb 26, 2026 | $0.67 est $0.67 | $202.7M est $199.9M | +1.6% |
| Nov 11, 2025 | $0.66 est $0.67 | $164.0M est $200.1M | −1.1% |
| Aug 6, 2025 | $0.81 est $0.71 | $164.2M est $189.9M | +16.3% |
| May 5, 2025 | $0.48 est $0.45 | $152.5M est $188.2M | −1.1% |
| Feb 26, 2025 | $0.51 est $0.70 | $180.4M est $173.1M | −6.4% |
| Nov 5, 2024 | $0.69 est $0.68 | $168.0M est $171.9M | +17.3% |
| Aug 13, 2024 | $0.73 est $0.82 | $167.2M est $162.3M | −6.8% |
| May 7, 2024 | $0.51 est $0.56 | $155.7M est $155.7M | −2.2% |
“Move” is the close of the first session after the report compared with the close of the last session before it, so it reads the same whether the company reported before the open or after the close.
U.S. Physical Therapy stock forecast and analyst price targets
Analysts’ average 12-month price target for U.S. Physical Therapy is $97.00, +12.9% from the last close, from 4 firms rating the stock in the last 90 days.
$97.00consensus 12-month target, +12.9% from the last close
Now $85.93Avg $97.00
Low $88High $98
Each firm’s latest rating in the last 90 days: 4 firms.
Latest analyst actions
| Date | Firm | Target | vs price |
|---|---|---|---|
| Sep 11 | J.P. Morgan | $95 | +10.6% |
| Aug 14 | William Blair | — | — |
| Aug 10 | Barrington | $98 | +14.0% |
| Aug 6 | Bank of America Securities | $88 | +2.4% |
| Aug 5 | William Blair | — | — |
−1.5%average 20-day move after past Neutral readings
+2.7%average move over the next 20 trading days in the last 5 years
±2.5%typical daily move, from the 14-day average range
Gekko doesn’t publish price predictions. These are analyst targets and historical base rates, which don’t guarantee future results.
U.S. Physical Therapy seasonality: the next 20 trading days
Over the next 20 trading days from Oct 10, U.S. Physical Therapy averaged +2.7% across the last 5 years, rising in 3 of them.
Next 20 trading days, by year
Average move and hit rate
| Window | Average | Years higher |
|---|---|---|
| Next 5 trading days | +1.2% | 2 of 5 |
| Next 10 trading days | +1.7% | 3 of 5 |
| Next 15 trading days | +2.6% | 3 of 5 |
| Next 20 trading days | +2.7% | 3 of 5 |
| Next 30 trading days | −0.8% | 2 of 5 |
For scale, USPH’s typical 20-trading-day move in either direction is about 6.5%.
U.S. Physical Therapy market cap and key statistics
U.S. Physical Therapy’s market cap is $1.31B, with a P/E ratio of 464 and revenue of $804.3M over the last twelve months.
Valuation
- Market cap
- $1.31B
- P/E ratio
- 464
- Forward P/E
- 27.3
- EPS, TTM
- $0.18
- Gekko Fair Value
- $71.90
Trading
- Volume
- 104,105
- Avg volume, 20 days
- 187,881
- 52-week high
- $93.50
- 52-week low
- $58.19
- Shares outstanding
- 14.92M
Financials
- Revenue, TTM
- $804.3M
- Profit margin
- 4%
- Return on equity
- 6.5%
- Quarterly earnings growth, YoY
- −56.5%
Risk and income
- Beta
- 1.11
- Typical daily move
- ±2.5%
- Typical 20-day move
- ±6.5%
- Dividend yield
- 2.19%
U.S. Physical Therapy stock news this week
Coverage of U.S. Physical Therapy this week reads positive: 3 positive, 2 neutral and 0 negative headlines.
- U.S. Physical Therapy stock trades below EUR 74.00 and Davis joined its boardAD HOC NEWS, Oct 8
- U.S. Physical Therapy appoints Myra Davis: analysts target U.S. Physical Therapy stock at USD 98.25AD HOC NEWS, Oct 7
- U.S. Physical Therapy stock reports 8.5 percent Q2 growthAD HOC NEWS, Oct 7
- USPH: Hospital Ties And Record Volumes Put Earnings At The CenterSimply Wall Street, Oct 5
- U.S. Physical Therapy stock reports 8.5 percent revenue growthAD HOC NEWS, Oct 5
U.S. Physical Therapy peers
U.S. Physical Therapy’s 6 largest industry peers by market value, with today’s move, GekkoIndex zone and gap to Gekko Fair Value.
| Stock | GekkoIndex zone | vs Fair Value |
|---|---|---|
| LHLabcorp | Neutral | 2.5% below |
| GHGuardant Health | Accumulation | 10.0% below |
| SOLVSolventum | Accumulation | 20.5% below |
| BTSGBrightSpring Health Services | Neutral | 2.8% above |
| EHCEncompass Health | Neutral | 7.3% above |
| DVADaVita | Neutral | 14.6% below |
A peer links to its own page where one exists.
U.S. Physical Therapy stock FAQ
What is U.S. Physical Therapy’s market cap?
U.S. Physical Therapy’s market cap is $1.31B at the Oct 12, 2026 close of $85.93, with 14.92M shares outstanding. The shares trade on a P/E ratio of 464.
What is the U.S. Physical Therapy stock forecast?
The consensus analyst 12-month price target for U.S. Physical Therapy is $97.00, +12.9% from the last close. Of the 4 firms that rated the stock in the last 90 days, 3 rate it a buy, 1 a hold and 0 a sell. Gekko doesn’t publish price predictions of its own.
Is U.S. Physical Therapy stock overvalued or undervalued?
On Gekko’s estimate U.S. Physical Therapy is overvalued: the Oct 12, 2026 close of $85.93 is 19.5% above Gekko Fair Value of $71.90. Gekko Fair Value is recalculated every trading day, and a gap inside 5% either way counts as about fair value.
When does U.S. Physical Therapy report earnings next?
U.S. Physical Therapy is expected to report on Nov 4, 2026 (23 days away). Analysts expect earnings of $0.76 per share on revenue of $214.5M. U.S. Physical Therapy beat the earnings estimate in 3 of its last 8 reports, moving 6.6% on average across the report.
What is U.S. Physical Therapy’s 52-week high and low?
U.S. Physical Therapy’s 52-week high is $93.50 and its 52-week low is $58.19; it closed at $85.93 on Oct 12, 2026, −3.3% over the past year. Over the last five years the shares peaked at $131.50 on Aug 1, 2022.
Is U.S. Physical Therapy stock a buy right now?
Gekko describes the data; it does not make buy or sell recommendations. On the swing-trade checklist, 3 of the 6 items with data read as supportive (trend, smart money and seasonality), 1 as mixed (gekkoindex) and 2 as headwinds (fair value and earnings risk). The checklist is a description of current data, not a recommendation.
How this page works
During US trading hours the price at the top of the page is a delayed quote, refreshed every 15 minutes; everything else is rebuilt after each US market close. The GekkoIndex, Gekko Fair Value and the checklist are Gekko’s own, and the Gekko Brief is written by AI from this page’s data and checked against it before it is published. How Gekko’s data works →
See U.S. Physical Therapy the way Gekko members do
Every GekkoIndex reading, insider trade, options bet and Congress disclosure plotted on the chart, plus the 5,800-name screener and trade planning tools.
Join 1,408 other traders using Gekko
Start Your FREE 7 Day Trial → Every feature unlocked. No credit card required.